| 标题 |
专利、报告等 AGA2115, a Bispecific Antibody Neutralizing DKK1 and Sclerostin, Increased Bone Formation, Decreased Bone Resorption, and Led to Significant BMD Gains in a First-in-Human, Single- and Multiple-dose, Placebo-Controlled Randomized Study
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 其它 | ASBMR 2025会议上的,摘要号1036 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |